Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Banning all drug promotion is the best option pending major reforms
Author: Mansfield, P.
Citation: Journal of Bioethical Inquiry, 2005; 2(2):75-81
Publisher: University of Otago, Bioethics Centre
Issue Date: 2005
ISSN: 1176-7529
Abstract: Drug promotion should be evaluated according to its impact on health, access to information, informed consent, and wealth. Drug promotion currently does more harm than good to each of these objectives because it is usually misleading. This is a systemic problem. Whilst improved regulation and education will address it to some degree, major reforms to payment systems for drug companies and doctors are also required. Until all these systemic reforms can be put in place, the best policy option is to ban the promotion of drugs to doctors and the public. Consequently, pending major reforms, it is appropriate for governments to restrict drug promotion as much as is politically achievable.
Keywords: Humans
Pharmaceutical Preparations
Government Regulation
Access to Information
Drug Industry
New Zealand
DOI: 10.1007/BF02448846
Published version:
Appears in Collections:Aurora harvest 6
General Practice publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.